Based on recent data, Actuate Therapeutics Inc (ACTU) shows an Average True Range (ATR) of 0.38 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 106.5K, indicating liquidity. These fundamental metrics provide insight into ACTU's underlying financial health and market activity.
| ATR | 0.38 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 106.5K |
| Avg Vol (10 Days) | 338.79K |
Actuate Therapeutics Inc (ACTU) technical indicators as of April 23, 2026: the SMA 20 is -9.12%, SMA 50 at -26.71%, and SMA 200 at -43.56%. The RSI 14 value is 34.21, suggesting its current momentum. These technical analysis signals help assess ACTU's price trends and potential future movements.
| SMA 20 | -9.12% |
| SMA 50 | -26.71% |
| SMA 200 | -43.56% |
| RSI 14 | 34.21 |
Actuate Therapeutics Inc (ACTU) stock performance overview as of April 23, 2026: The 52-week high is $11.99 (currently -67.06% below), and the 52-week low is $1.58 (currently 6.33% above). Over the past year, ACTU's performance is -34.97%, compared to the S&P 500's 24.91% change.
| 52-Week High | 11.99 |
| 52-Week High Chg | -67.06% |
| 52-Week Low | 1.58 |
| 52-Week Low Chg | +6.33% |
| S&P 500 52-Week Chg | 24.91% |
According to market data, Actuate Therapeutics Inc (ACTU) stock's recent performance metrics show that over the last month, ACTU is -18.95%, with a Year-to-Date (YTD) performance of -9.15%. Over the past year, the stock has seen a -34.97% change. These figures summarize ACTU's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 3.1 | 3.1 | 5.89 | 8.27 | 11.99 | 7.05 |
| Low | 1.92 | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 |
| Performance | -3.30% | -18.95% | -25.67% | -1.77% | -34.97% | -9.15% |
According to current financial data, ACTU stock's P/E (TTM) ratio is -2.37, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ACTU, including P/S (N/A), P/B (6.64), and P/FCF (-2.77), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ACTU | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.37 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 6.64 | 0.21 | 0.6 | 5 |
| P/FCF (TTM) | -2.77 | -13.01 | -438.66 | 34.75 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep